Sac/Val Heart Failure Benefit Extends to Diabetes Patients Sac/Val Heart Failure Benefit Extends to Diabetes Patients
The beneficial effects of sacubitril/valsartan on reverse cardiac remodeling in patients with heart failure and reduced ejection fraction extend to patients with type 2 diabetes, new research shows.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news
More News: Cardiology | Diabetes | Diabetes Type 2 | Diovan | Endocrinology | Health | Heart | Heart Failure